Absorption |
Blood-Brain Barrier | BBB+ | 0.9814 |
Human Intestinal Absorption | HIA+ | 0.9862 |
Caco-2 Permeability | Caco2- | 0.5087 |
P-glycoprotein Substrate | Substrate | 0.6315 |
P-glycoprotein Inhibitor | Inhibitor | 0.6518 |
Inhibitor | 0.5991 |
Renal Organic Cation Transporter | Inhibitor | 0.6706 |
Distribution |
Subcellular localization | Mitochondria | 0.6973 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8848 |
CYP450 2D6 Substrate | Non-substrate | 0.5000 |
CYP450 3A4 Substrate | Non-substrate | 0.5714 |
CYP450 1A2 Inhibitor | Inhibitor | 0.8906 |
CYP450 2C9 Inhibitor | Inhibitor | 0.6520 |
CYP450 2D6 Inhibitor | Inhibitor | 0.8377 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.5372 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8033 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.9223 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Strong inhibitor | 0.5443 |
Inhibitor | 0.8653 |
AMES Toxicity | Non AMES toxic | 0.9133 |
Carcinogens | Non-carcinogens | 0.8876 |
Fish Toxicity | Low FHMT | 0.6224 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9775 |
Honey Bee Toxicity | Low HBT | 0.9229 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | II | 0.7458 |
Carcinogenicity (Three-class) | Non-required | 0.5637 |